Trump announces Most Favored Nation deals with nine drug companies

President Trump announced 'Most Favored Nation' drug pricing deals with nine pharmaceutical companies to help lower medication costs for U.S. patients. The agreements follow prior deals with five companies and aim to price U.S. medications at the lowest rates available globally.

While officials claim these deals will significantly reduce prices, experts express skepticism about the impact on consumers. The companies involved include major names like Amgen and Merck.

Each has agreed to sell medicines to Medicaid at lower prices and invest over $150 billion in U.S. projects. However, details remain unclear, raising doubts about actual savings for most Americans.